Search
for
Sort by
Research 30 of 759
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Endocrine intervention for transsexuals
- Physiological and biological skin changes in pregnancy
- Complications of Rhytidectomy
- Hormonal therapies for acne
- Care Considerations and Management of Transgender Individuals After Kidney Transplantation: A Single Institution Experience and Literature Review
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Gender-Affirming Hormone Therapy for Transgender Females
- HORMONAL IMPLANTS, BEAUTY CHIP; BENEFITS AND HARMFUL
- Cardiovascular risk factors and events in women with androgen excess
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation
- (024) Monitored Hormone Therapy in Women 70 Years and Older: Aging Does Not Mean Sexual Retirement
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Drug news and therapeutic news
- Long-Term Effects of COVID-19
- Hormonal Treatment of Transgender Women with Oral Estradiol
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Management of Toxicities of Targeted Therapies
- Clinical assessment of the local tolerance and cosmetic efficacy of a topical skin care formulation used after 70% glycolic acid facial skin rejuvenation procedures in healthy female subjects: A randomized, controlled, evaluator-blind study
- Clinical characteristics and outcomes of patients with superficial venous thrombosis at multiple sites simultaneously
- Sex hormones and related compounds, including hormonal contraceptives
- Venous thromboembolism and women's health
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024